Clinical Trial Update: Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

View source ↗

Summary

The study evaluates whether FET-PET imaging can effectively monitor treatment in glioblastoma multiforme patients. Results from this completed trial provide ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• FET-PET imaging (18F-fluoroethyltyrosine) ([18F]Fluoroethyltyrosine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Glioblastoma Multiforme | Status: COMPLETED